Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Détails
ID Serval
serval:BIB_8E741C11DD82
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Périodique
Blood pressure
ISSN
1651-1999 (Electronic)
ISSN-L
0803-7051
Statut éditorial
Publié
Date de publication
06/2019
Peer-reviewed
Oui
Volume
28
Numéro
3
Pages
144-145
Langue
anglais
Notes
Publication types: Editorial
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Antibodies, Monoclonal, Humanized/therapeutic use, Anticholesteremic Agents/therapeutic use, Cardiovascular Diseases/etiology, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Cholesterol/metabolism, Clinical Trials as Topic/methods, Enzyme Inhibitors/therapeutic use, Humans, Hypertension/complications, Hypertension/drug therapy, Proprotein Convertase 9/antagonists & inhibitors, Risk Factors, Risk Reduction Behavior
Pubmed
Web of science
Open Access
Oui
Création de la notice
03/06/2019 16:19
Dernière modification de la notice
16/02/2021 6:27
Données d'usage
